What is the latest news on BVXV?

Quantisnow has not tracked any new filings, ratings or press releases for BVXV in the last 30 days. The most recent wire item was published on February 14, 2024.

Where does BVXV stock trade?

BiondVax Pharmaceuticals Ltd. (BVXV) is listed on NASDAQ.

What sector and industry is BVXV in?

BiondVax Pharmaceuticals Ltd. operates in the Health Care sector, Biotechnology: Biological Products (No Diagnostic Substances) industry.

When did BiondVax Pharmaceuticals Ltd. go public?

BiondVax Pharmaceuticals Ltd. (BVXV) completed its IPO in 2015.

What are analysts saying about BVXV?

BiondVax Pharmaceuticals Ltd. has had 1 recent analyst action on file. The most recent action was from Aegis Capital: Buy with a $700.00 price target on 2022-01-26. Recent price targets cluster around $700.00.

What companies are similar to BVXV?

Notable peers in the same industry include AMGN (Amgen Inc.), GILD (Gilead Sciences Inc.), MRNA (Moderna Inc.), ARGX (argenx SE), RVMD (Revolution Medicines Inc.). Compare BVXV side-by-side with any of them on Quantisnow.

How can I track BVXV on Quantisnow?

Quantisnow aggregates BiondVax Pharmaceuticals Ltd.'s SEC filings, analyst ratings, insider transactions, FDA approvals, and press releases the moment they hit the wire (Wall Street's wire, on your screen.). Follow BVXV to receive live email and push alerts on every new disclosure.

BVXV

NASDAQ

BiondVax Pharmaceuticals Ltd.

SectorHealth Care IndustryBiotechnology: Biological Products (No Diagnostic Substances)IPO2015

$1.32-0.03 (-2.22%)

Follow Website

BiondVax Pharmaceuticals Ltd. (BVXV) is a Biotechnology: Biological Products (No Diagnostic Substances) company listed on NASDAQ. There were no new wire items for BVXV in the last 30 days. The most recent was published Feb 14, 2024.

BiondVax Pharmaceuticals Ltd., a development stage biopharmaceutical company, focuses on developing, manufacturing, and commercializing products for the prevention and treatment of infectious diseases and related illnesses in Israel. The company was incorporated in 2003 and is headquartered in Jerusalem, Israel.

Latest news

25 items

BVXV FAQ

8 questions

What does BiondVax Pharmaceuticals Ltd. do?
BiondVax Pharmaceuticals Ltd., a development stage biopharmaceutical company, focuses on developing, manufacturing, and commercializing products for the prevention and treatment of infectious diseases and related illnesses in Israel. The company was incorporated in 2003 and is headquartered in Jerusalem, Israel.
What is the latest news on BVXV?
Quantisnow has not tracked any new filings, ratings or press releases for BVXV in the last 30 days. The most recent wire item was published on February 14, 2024.
Where does BVXV stock trade?
BiondVax Pharmaceuticals Ltd. (BVXV) is listed on NASDAQ.
What sector and industry is BVXV in?
BiondVax Pharmaceuticals Ltd. operates in the Health Care sector, Biotechnology: Biological Products (No Diagnostic Substances) industry.
When did BiondVax Pharmaceuticals Ltd. go public?
BiondVax Pharmaceuticals Ltd. (BVXV) completed its IPO in 2015.
What are analysts saying about BVXV?
BiondVax Pharmaceuticals Ltd. has had 1 recent analyst action on file. The most recent action was from Aegis Capital: Buy with a $700.00 price target on 2022-01-26. Recent price targets cluster around $700.00.
What companies are similar to BVXV?
Notable peers in the same industry include AMGN (Amgen Inc.), GILD (Gilead Sciences Inc.), MRNA (Moderna Inc.), ARGX (argenx SE), RVMD (Revolution Medicines Inc.). Compare BVXV side-by-side with any of them on Quantisnow.
How can I track BVXV on Quantisnow?
Quantisnow aggregates BiondVax Pharmaceuticals Ltd.'s SEC filings, analyst ratings, insider transactions, FDA approvals, and press releases the moment they hit the wire (Wall Street's wire, on your screen.). Follow BVXV to receive live email and push alerts on every new disclosure.